期刊文献+

Effects of tacrolimus (FK506) on sciatic nerve regeneration in rats 被引量:1

Effects of tacrolimus (FK506) on sciatic nerve regeneration in rats
下载PDF
导出
摘要 BACKGROUND: Tacrolimus (FK506) protects peripheral nerves located in damaged regions by inhibiting T lymphocyte proliferation and activation. OBJECTIVE: To evaluate the effect of FK506 on promoting regeneration of rat sciatic nerve. DESIGN, TIME AND SETTING: A randomized, controlled, animal study was performed at the Laboratory of the Department of Orthopedic Surgery, Dalian Medical University, China, from September 2007 to September 2008. MATERIALS: A total of 60 adult, male, Sprague-Dawley rats were equally and randomly divided into model, local administration and systemic administration groups. All rats received a neurotomy of bilateral sciatic nerves to establish models of nerve regeneration chambers. The powder and injection of FK506 were supplied by Fujisawa Pharmaceutical, Japan. METHODS: The regeneration chambers of the model group were infused with 0.2 mL saline. The systemic group were injected with 0.2 mL saline, followed by daily subcutaneous injections of FK506 (1 mg/kg), for 14 days. The local administration group was infused with 0.2 mL FK506 (1 μg/mL). MAIN OUTCOME MEASURES: Local immune response was observed using hematoxylin-eosin staining. Myelinated nerve fiber number, myelin sheath and nerve fiber thickness were observed using toluidine blue staining. Wet weight of gastrocnemius was evaluated. Compound muscle action potential amplitude, latency, and conduction time were recorded, and motor nerve conduction velocity was calculated using electrophysiology. RESULTS: The total number of myelinated nerve fibers in the local and systemic administration groups was significantly higher than in the model group. The density of myelinated nerve fibers, myelin sheath thickness and mean axon diameter were significantly increased in the systemic administration group compared with the model group (P 〈 0.05). Lymphocyte infiltration was decreased in the local and systemic administration groups compared with the model group. The wet weight of rat gastrocnemius in the local and systemic administration groups were significantly greater compared with the model group (P 〈 0.05). Motor nerve conduction velocity was the fastest in the systemic administration group, and the slowest in the model group. Compound muscle action potential amplitude was larger in the systemic administration group compared with the local administration and model groups (P 〈 0.05). CONCLUSION: Systemic administration of FK506 can promote regeneration of rat sciatic nerve and recovery of neural function. Systemic administration produced better regeneration and recovery of function than local administration of FK506. BACKGROUND: Tacrolimus (FK506) protects peripheral nerves located in damaged regions by inhibiting T lymphocyte proliferation and activation. OBJECTIVE: To evaluate the effect of FK506 on promoting regeneration of rat sciatic nerve. DESIGN, TIME AND SETTING: A randomized, controlled, animal study was performed at the Laboratory of the Department of Orthopedic Surgery, Dalian Medical University, China, from September 2007 to September 2008. MATERIALS: A total of 60 adult, male, Sprague-Dawley rats were equally and randomly divided into model, local administration and systemic administration groups. All rats received a neurotomy of bilateral sciatic nerves to establish models of nerve regeneration chambers. The powder and injection of FK506 were supplied by Fujisawa Pharmaceutical, Japan. METHODS: The regeneration chambers of the model group were infused with 0.2 mL saline. The systemic group were injected with 0.2 mL saline, followed by daily subcutaneous injections of FK506 (1 mg/kg), for 14 days. The local administration group was infused with 0.2 mL FK506 (1 μg/mL). MAIN OUTCOME MEASURES: Local immune response was observed using hematoxylin-eosin staining. Myelinated nerve fiber number, myelin sheath and nerve fiber thickness were observed using toluidine blue staining. Wet weight of gastrocnemius was evaluated. Compound muscle action potential amplitude, latency, and conduction time were recorded, and motor nerve conduction velocity was calculated using electrophysiology. RESULTS: The total number of myelinated nerve fibers in the local and systemic administration groups was significantly higher than in the model group. The density of myelinated nerve fibers, myelin sheath thickness and mean axon diameter were significantly increased in the systemic administration group compared with the model group (P 〈 0.05). Lymphocyte infiltration was decreased in the local and systemic administration groups compared with the model group. The wet weight of rat gastrocnemius in the local and systemic administration groups were significantly greater compared with the model group (P 〈 0.05). Motor nerve conduction velocity was the fastest in the systemic administration group, and the slowest in the model group. Compound muscle action potential amplitude was larger in the systemic administration group compared with the local administration and model groups (P 〈 0.05). CONCLUSION: Systemic administration of FK506 can promote regeneration of rat sciatic nerve and recovery of neural function. Systemic administration produced better regeneration and recovery of function than local administration of FK506.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2009年第5期333-338,共6页 中国神经再生研究(英文版)
基金 the Scientific Research Foundation of Education Department of Liaoning Province in China, No.9707221070
关键词 tacrolimus (FK506) neural regeneration sciatic nerve tacrolimus (FK506) neural regeneration sciatic nerve
  • 相关文献

参考文献22

  • 1Hart IK,Sharshar T,Sathasivam S.Immunosuppressant drugs for myasthenia gravis.J Neurol Neurosurg Psychiatry.2009;80(1):5-6.
  • 2Jeon SH,Kim SJ,Kim JS,et al.Immunosuppressant FK506 decreases the intracellular magnesium in the human osteoblast cell by inhibiting the ERK1/2 pathway.Life Sci.2009;84(1-2):23-27.
  • 3Chou NK,Wang SS,Chen YS,et al.Induction immunosuppression with basiliximab in heart transplantation.Transplant Proc.2008;40(8):2623-2625.
  • 4Nassar CA,Nassar PO,Andia DC,et al.Biochemical evaluation of glycemic levels of long-term tacrolimus therapy in rats.Braz Oral Res.2007;21 (4):293-297.
  • 5Marquet P,Djebli N,Picard N.Pharmacogenetics and immunosuppressor drugs:impact and clinical interest in transplantation.Ann Pharm Fr.2007;65(6):382-389.
  • 6Winkler M.Cyclosporin as baseline immunosuppression in solid organ transplantation.BioDrugs.2000;14(3):185-193.
  • 7Snyder AK,Fox IK,Nichols CM,et al.Neuroregenerative effects of preinjury FK-506 administration.Plast Reconstr Surg.2006; 118(2):360-367.
  • 8Voda J,Yamaji T,Gold BG.Neuroimmunophilin ligands improve functional recovery and increase axonal growth after spinal cord hemisection in rats.J Neurotrauma.2005;22(10):1150-1161.
  • 9Lagoda G,Sezen SF,Liu T,et al.FK506-binding protein Iocalizations in human penile innervation.BJU Int.2008; 101 (5):604-609.
  • 10Mulhall J.Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat:new experimental paradigms.Eur Urol.2007;51 (6):1488-1489.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部